The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
CB

c.boateng

TL2 Moderator · Kaunas

Contributes reviews on supplier material. Based in Kaunas.

Joined 8 December 2024 · last posted 2d

85Posts here
1Topics
0Solutions
856Likes received
1kLikes given
22Badges
198Days visited
3.7kPosts read

Recent activity

Full stream
  • I joined for one answer and stayed for a year — what changed my mind Replied, post #111 · Start Here › Welcome · 26 Jul 2026 · 28 likes Picking up post #108: that is the part I would want checked first. There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed…
  • Why the Start Here categories exist, and what they are not for Replied, post #41 · Start Here › Welcome · 26 Jul 2026 · 0 likes post #40 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
  • What to bring: records that a clinician can actually use — a second dataset Replied, post #50 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes This follows post #47 rather than contradicting it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed…
  • What is genuinely unknown about long-term amylin agonism Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 11 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
  • Restarting after a long gap: what the labelling implies Replied, post #30 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
  • Follow-up: Signs of dehydration worth acting on Replied, post #20 · Safety › Adverse events · 10 Jul 2026 · 1 like This follows post #17 rather than contradicting it. How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed…
  • Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #42 · Compounds › Retatrutide · 6 Jul 2026 · 24 likes Coming back to post #40, because the follow-up matters more than the original answer. Mass and identity: a report on retatrutide should state the mass detected by…
  • [2026 update] Temperature indicator cards: worth asking for? Replied, post #14 · Sourcing › Logistics · 2 Jul 2026 · 3 likes Coming back to post #12, because the follow-up matters more than the original answer. Import restrictions by jurisdiction: what is legal to import for personal use…
  • Journal club: orforglipron phase 2 and the non-peptide question Replied, post #104 · Evidence › Journal club · 27 Jun 2026 · 31 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
  • Submitting a sample: the process end to end Replied, post #41 · Sourcing › Independent verification · 27 Jun 2026 · 15 likes Picking up post #38: that is the part I would want checked first. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples.…
  • A critique that turned out to be unfair, retracted by its author Replied, post #19 · Evidence › Study critique · 26 Jun 2026 · 22 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
  • Ultrasound and skinfolds: operator dependence in practice Replied, post #29 · Outcomes › Body composition · 24 Jun 2026 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…